Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews · Hepato-Biliary

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 3 · 75%Low 1 · 25%Moderate 0 · 0%High 0 · 0%

Adverse events ‐ Overt hepatic encephalopathy ( · people with hepatic encephalopathy

The intervention may leads to lower adverse events ‐ Overt hepatic encephalopathy ( (low certainty).

1 finding from 1 review

Probiotics for people with hepatic encephalopathy 2017 · Cochrane Headline outcomes only
RR 0.29 [0.16, 0.51]
10 studies · 585 participants
Low

Adverse events ‐ Overt hepatic encephalopathy ( · people with hepatic encephalopathy

It is very uncertain whether the intervention changes adverse events ‐ Overt hepatic encephalopathy ( (very low certainty).

1 finding from 1 review

Probiotics for people with hepatic encephalopathy 2017 · Cochrane Headline outcomes only
RR 1.17 [0.63, 2.17]
6 studies · 420 participants
Very low

Adverse events ‐ Change of/or withdrawal from treatment ( · people with hepatic encephalopathy

It is very uncertain whether the intervention changes adverse events ‐ Change of/or withdrawal from treatment ( (very low certainty).

1 finding from 1 review

Probiotics for people with hepatic encephalopathy 2017 · Cochrane Headline outcomes only
RR 1.27 [0.88, 1.82]
7 studies · 490 participants
Very low

Adverse events ‐ Change of/or withdrawal from treatment ( · people with hepatic encephalopathy

It is very uncertain whether the intervention changes adverse events ‐ Change of/or withdrawal from treatment ( (very low certainty).

1 finding from 1 review

Probiotics for people with hepatic encephalopathy 2017 · Cochrane Headline outcomes only
RR 0.7 [0.46, 1.07]
9 studies · 551 participants
Very low